Zobrazeno 1 - 3
of 3
pro vyhledávání: '"Abdullah N. Almajed"'
Autor:
Marwan A. Alrasheed, Khalid A. Alamer, Mashael Albishi, Abdulrahman A. Alsuhibani, Omar A. Almohammed, Abdulrahman Alwhaibi, Abdullah N. Almajed, Jeff J. Guo
Publikováno v:
Pharmaceuticals, Vol 17, Iss 7, p 815 (2024)
Background: New multiple myeloma (MM) medications have revolutionized the treatment landscape, but they are also associated with a range of adverse events (AEs). This study aims to provide a comprehensive overview of AEs reported for four new MM medi
Externí odkaz:
https://doaj.org/article/5cb04df204e946929d17126293472b9f
Autor:
Alrasheed, Marwan A.1 (AUTHOR) malrasheed1@ksu.edu.sa, Alamer, Khalid A.2 (AUTHOR) kaalamer@iau.edu.sa, Albishi, Mashael1 (AUTHOR) oalmohammed@ksu.edu.sa, Alsuhibani, Abdulrahman A.3 (AUTHOR) aa.alsuhibani@qu.edu.sa, Almohammed, Omar A.1 (AUTHOR) aalwhaibi@ksu.edu.sa, Alwhaibi, Abdulrahman1 (AUTHOR), Almajed, Abdullah N.4 (AUTHOR) abdullah.n.almajid@gmail.com, Guo, Jeff J.5 (AUTHOR) guoje@ucmail.uc.edu
Publikováno v:
Pharmaceuticals (14248247). Jul2024, Vol. 17 Issue 7, p815. 18p.
Publikováno v:
Immunotherapy Weekly; 7/9/2024, p720-720, 1p